06/06/2025 3:53 PM | Amicus Therapeutics (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2025 3:54 PM | Amicus Therapeutics (Issuer) Kelly Michael Aaron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2025 3:58 PM | Amicus Therapeutics (Issuer) SBLENDORIO GLENN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2025 3:58 PM | Amicus Therapeutics (Issuer) RAAB MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2025 8:30 AM | Amicus Therapeutics (Subject) Avoro Capital Advisors LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025 6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2025 5:00 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2025 4:01 PM | Amicus Therapeutics (Filer)
| Form DEF 14A | |
04/24/2025 4:02 PM | Amicus Therapeutics (Filer)
| Form DEFA14A | |
04/24/2025 4:03 PM | Amicus Therapeutics (Filer)
| Form ARS | |
04/23/2025 7:14 PM | Amicus Therapeutics (Subject) BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for FOLD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Amicus Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
03/18/2025 4:56 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2025 6:27 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 7:00 PM | Amicus Therapeutics (Subject) Redmile Group, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025 4:14 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2025 4:17 PM | Amicus Therapeutics (Issuer) Clark David Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2025 4:19 PM | Amicus Therapeutics (Issuer) Castelli Jeff (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2025 4:22 PM | Amicus Therapeutics (Issuer) Prout Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2025 4:00 PM | Amicus Therapeutics (Issuer) Rosenberg Ellen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 9:25 AM | Amicus Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
01/13/2025 6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/06/2025 6:02 PM | Amicus Therapeutics (Issuer) Harford Simon N.R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 6:03 PM | Amicus Therapeutics (Issuer) Castelli Jeff (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 6:04 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 6:05 PM | Amicus Therapeutics (Issuer) Clark David Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 6:06 PM | Amicus Therapeutics (Issuer) Prout Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 6:06 PM | Amicus Therapeutics (Issuer) Rosenberg Ellen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 5:12 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2024 3:43 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 8:00 PM | Amicus Therapeutics (Subject) Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024 10:37 AM | Amicus Therapeutics (Subject) WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
11/14/2024 8:31 AM | Amicus Therapeutics (Subject) Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/08/2024 9:52 AM | Amicus Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024 4:49 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 4:03 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024 6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 5:23 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 3:49 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024 6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 12:24 PM | Amicus Therapeutics (Subject) JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
Trump’s New Order Could Boost Social Security Benefits by 400% (Ad) If you collect—or plan to collect—Social Security, you need to see this.
A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse...
...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier. Click here to watch the full presentation before it's too late. |
10/04/2024 3:05 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 3:35 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024 3:19 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024 4:10 PM | Amicus Therapeutics (Issuer) Harford Simon N.R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/05/2024 7:10 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/09/2024 4:01 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 3:22 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |